In our department, we are working on both basic research and clinical research to elucidate the pathology of glaucoma, which is the leading cause of acquired blindness in Japan, and to develop new treatment methods. Specifically, we are aiming 1) to search for new intraocular pressure-lowering drugs and drug delivery methods by elucidating the mechanism by which intraocular pressure rises, 2) to analyze risk factors for glaucoma surgery results and to research surgical techniques and adjuvant drugs with high efficacy and safety, 3) to develop therapeutic methods based on neuroprotective mechanisms that respond to glaucoma optic neuropathy. We also work on the treatment of ocular complications associated with leprosy and familial amyloidotic polyneuropathy.

Fundus photography of glaucomatous eye.
It shows enlargement of optic nerve head cup with peripapillary chorioretinal atrophy.